Syngene International Limited — Board Meeting, 23-01-2025: Outcome of Board Meeting

The Board of Directors of Syngene International Limited has approved the unaudited financial results for the quarter and nine months ended December 31, 2024. The consolidated revenue from operations stood at ₹9,437 crore, with a net profit of ₹1,311 crore for the period. The results reflect strong year-on-year growth in both standalone and consolidated revenues, driven by operational efficiency and expanded capabilities following the recent acquisition of a biologics manufacturing facility. This strategic move is expected to enhance production capacity and service offerings in the biopharmaceutical sector.